Many hospitalized heart patients not getting protective statin medications upon discharge

Patients with peripheral artery disease (PAD) are at high risk of heart attack, stroke and cardiovascular death. In addition, PAD patients can suffer major adverse limb events, such as acute limb ischemia - the equivalent of a heart attack in the leg - that can lead to limb loss. Managing PAD is challenging for patients and physicians alike - despite best available treatment including high-intensity statins, risk of cardiovascular and limb events remains high. With few clinical trials focused on patients with PAD, physicians must often extrapolate from studies in broader populations with atherosclerosis about the best treatment approach for these patients. Unfortunately, few of these studies have characterized limb risk and fewer have demonstrated benefits of preventive therapies in reducing this risk. A new sub-analysis of the FOURIER clinical trial, however, now offers information on the safety and effectiveness of giving the PCSK9 inhibitor evolocumab on top of statin therapy to this high-risk population.

Many hospitalized heart patients not getting protective statin medications upon discharge

While patients who are discharged from the hospital after treatment for heart disease, cerebrovascular disease, or peripheral artery disease, should be on statin medications to reduce their ...

Tue 14 Nov 17 from Medical Xpress

High-dose statin drugs more effective than low doses in Japanese patients

For years, Asian doctors haven't had the kind of solid evidence that U.S. doctors have had to show high-dose statins could lower heart risks in their patients. But a large new study released ...

Tue 14 Nov 17 from Medical Xpress

PCSK9 Inhibitor improves outcomes for patients with peripheral artery disease

Patients with peripheral artery disease (PAD) are at high risk of heart attack, stroke and cardiovascular death. In addition, PAD patients can suffer major adverse limb events, such as acute ...

Mon 13 Nov 17 from Medical Xpress

PCSK9 Inhibitor improves outcomes for patients with peripheral artery disease, Mon 13 Nov 17 from Eurekalert

Follow-up cholesterol testing reduces risk of reocurrence for heart attack and stroke patients

If you have a heart attack or stroke, it's important to get your "bad" cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated ...

Mon 13 Nov 17 from Medical Xpress

Follow-up cholesterol testing reduces risk of reocurrence for heart attack and stroke patients, Sun 12 Nov 17 from Eurekalert

Reduction in common heart hormone associated with improved outcomes and lower mortality

Heart failure patients discharged from the hospital with a reduced level of a common hormone produced by the heart had significantly lower rates of readmission and lower death rates, according ...

Mon 13 Nov 17 from Medical Xpress

Reduction in common heart hormone associated with improved outcomes and lower mortality, Sun 12 Nov 17 from Eurekalert

Heart attack and stroke patients prescribed statin medication upon discharge have better outcomes

Patients with a prior history of heart attacks or stroke have better outcomes when cholesterol-lowering medications are used after they're discharged from the hospital, according to a new study ...

Sun 12 Nov 17 from Medical Xpress

Heart's pumping function is not an indicator of heart failure survival rates

Contrary to popular practice, a measure of the heart's pumping function known as "left ventricular ejection fraction" is not associated with the long-term outcomes of hospitalized heart failure ...

Sun 12 Nov 17 from Medical Xpress

Bookmark

Bookmark and Share